Get all your news in one place.
100's of premium titles.
One app.
Start reading
Evening Standard
Evening Standard
World
William Mata

What is Lecanemab and who makes it? Alzheimer’s drug gets approval but will not be available on the NHS

A new drug that could slow the progression of Alzheimer’s disease has been approved as safe to use – but it has also been deemed as too costly to be prescribed on the NHS.

The Medicines and Healthcare products Regulatory Agency (MHRA) has on Thursday said Lecanemab is safe and effective, reports Sky News.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.